US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist

16.2548
-0.5752-3.42%

Close Nov 29 13:00 ET

16.2548
0.00000.00%

Post 17:01 ET

21.46MMarket Cap-1342P/E (TTM)

Pieris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-97.26%53K

65.28%42.81M

-77.78%1.3M

263.50%19.52M

442.32%20.06M

-82.38%1.94M

-17.56%25.9M

-30.76%5.85M

Operating revenue

--0

-97.26%53K

65.28%42.81M

-77.78%1.3M

263.50%19.52M

442.32%20.06M

-82.38%1.94M

-17.56%25.9M

-30.76%5.85M

Cost of revenue

Gross profit

Operating expense

-80.92%3.14M

-74.54%4.18M

-65.26%5.36M

-10.07%55.04M

-51.47%6.78M

2.27%16.43M

10.54%16.41M

-5.49%15.42M

-23.08%61.2M

-23.83%13.97M

Selling and administrative expenses

-47.64%3.58M

-6.50%3.43M

2.86%4.14M

2.80%16.85M

-41.61%2.33M

73.18%6.84M

-10.22%3.66M

-8.13%4.02M

-1.20%16.39M

-2.45%3.99M

-General and administrative expense

-47.64%3.58M

-6.50%3.43M

2.86%4.14M

2.80%16.85M

-41.61%2.33M

73.18%6.84M

-10.22%3.66M

-8.13%4.02M

-1.20%16.39M

-2.45%3.99M

Research and development costs

-104.65%-446K

-94.76%751K

-90.93%1.22M

-21.10%41.8M

-66.71%4.45M

-29.39%9.6M

19.93%14.33M

-4.56%13.42M

-20.51%52.98M

-12.87%13.38M

Other operating expenses

----

55.81%-3.61M

--0

----

-33.78%-1.58M

4.79%-2.03M

-121.79%-8.17M

-209.68%-3.39M

Operating profit

-201.59%-3.14M

-214.53%-4.18M

60.67%-5.3M

65.35%-12.23M

32.55%-5.48M

128.84%3.09M

132.72%3.65M

-153.11%-13.48M

26.68%-35.3M

17.93%-8.13M

Net non-operating interest income expense

-69.22%169K

-58.98%201K

-32.77%240K

156.73%1.85M

29.63%455K

127.80%549K

271.21%490K

12,000.00%357K

17,925.00%721K

5,950.00%351K

Non-operating interest income

-69.22%169K

-58.98%201K

-32.77%240K

156.73%1.85M

29.63%455K

127.80%549K

271.21%490K

--357K

17,925.00%721K

5,950.00%351K

Other net income (expense)

100.55%79K

339.75%386K

400.00%171K

-1,186.88%-14.16M

236.31%443K

-2,089.90%-14.39M

-123.82%-161K

-124.89%-57K

-45.80%1.3M

-185.98%-325K

Special income (charges)

--0

----

---13.91M

--981K

---14.89M

----

--0

-Less:Impairment of capital assets

--0

----

--13.91M

---981K

--14.89M

----

--0

Other non- operating income (expenses)

-84.39%79K

339.75%386K

400.00%171K

-119.19%-250K

-65.54%-538K

-30.01%506K

-123.82%-161K

-124.89%-57K

-45.80%1.3M

-185.98%-325K

Income before tax

73.15%-2.89M

-190.29%-3.59M

62.89%-4.89M

26.25%-24.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

27.24%-33.28M

15.00%-8.1M

Income tax

Net income

73.15%-2.89M

-190.29%-3.59M

62.89%-4.89M

26.25%-24.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

27.24%-33.28M

15.00%-8.1M

Net income continuous Operations

73.15%-2.89M

-190.29%-3.59M

62.89%-4.89M

26.25%-24.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

27.24%-33.28M

15.00%-8.1M

Minority interest income

Net income attributable to the parent company

73.15%-2.89M

-190.29%-3.59M

62.89%-4.89M

26.25%-24.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

27.24%-33.28M

15.00%-8.1M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

73.15%-2.89M

-190.29%-3.59M

62.89%-4.89M

26.25%-24.54M

43.42%-4.58M

-10.44%-10.75M

138.46%3.98M

-158.44%-13.18M

27.24%-33.28M

15.00%-8.1M

Basic earnings per share

74.83%-2.19

-176.03%-2.76

72.08%-3.95

40.00%-21.6

62.84%-3.27

16.35%-8.7

132.41%3.63

-152.68%-14.15

36.62%-36

15.38%-8.8

Diluted earnings per share

74.83%-2.19

-176.24%-2.76

72.08%-3.95

40.00%-21.6

62.84%-3.27

16.35%-8.7

132.32%3.62

-152.68%-14.15

36.62%-36

15.38%-8.8

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	-97.26%53K	65.28%42.81M	-77.78%1.3M	263.50%19.52M	442.32%20.06M	-82.38%1.94M	-17.56%25.9M	-30.76%5.85M
Operating revenue	--0	--0	-97.26%53K	65.28%42.81M	-77.78%1.3M	263.50%19.52M	442.32%20.06M	-82.38%1.94M	-17.56%25.9M	-30.76%5.85M
Cost of revenue
Gross profit
Operating expense	-80.92%3.14M	-74.54%4.18M	-65.26%5.36M	-10.07%55.04M	-51.47%6.78M	2.27%16.43M	10.54%16.41M	-5.49%15.42M	-23.08%61.2M	-23.83%13.97M
Selling and administrative expenses	-47.64%3.58M	-6.50%3.43M	2.86%4.14M	2.80%16.85M	-41.61%2.33M	73.18%6.84M	-10.22%3.66M	-8.13%4.02M	-1.20%16.39M	-2.45%3.99M
-General and administrative expense	-47.64%3.58M	-6.50%3.43M	2.86%4.14M	2.80%16.85M	-41.61%2.33M	73.18%6.84M	-10.22%3.66M	-8.13%4.02M	-1.20%16.39M	-2.45%3.99M
Research and development costs	-104.65%-446K	-94.76%751K	-90.93%1.22M	-21.10%41.8M	-66.71%4.45M	-29.39%9.6M	19.93%14.33M	-4.56%13.42M	-20.51%52.98M	-12.87%13.38M
Other operating expenses	----	----	----	55.81%-3.61M	--0	----	-33.78%-1.58M	4.79%-2.03M	-121.79%-8.17M	-209.68%-3.39M
Operating profit	-201.59%-3.14M	-214.53%-4.18M	60.67%-5.3M	65.35%-12.23M	32.55%-5.48M	128.84%3.09M	132.72%3.65M	-153.11%-13.48M	26.68%-35.3M	17.93%-8.13M
Net non-operating interest income expense	-69.22%169K	-58.98%201K	-32.77%240K	156.73%1.85M	29.63%455K	127.80%549K	271.21%490K	12,000.00%357K	17,925.00%721K	5,950.00%351K
Non-operating interest income	-69.22%169K	-58.98%201K	-32.77%240K	156.73%1.85M	29.63%455K	127.80%549K	271.21%490K	--357K	17,925.00%721K	5,950.00%351K
Other net income (expense)	100.55%79K	339.75%386K	400.00%171K	-1,186.88%-14.16M	236.31%443K	-2,089.90%-14.39M	-123.82%-161K	-124.89%-57K	-45.80%1.3M	-185.98%-325K
Special income (charges)	--0	----	----	---13.91M	--981K	---14.89M	----	----	--0	--0
-Less:Impairment of capital assets	--0	----	----	--13.91M	---981K	--14.89M	----	----	--0	--0
Other non- operating income (expenses)	-84.39%79K	339.75%386K	400.00%171K	-119.19%-250K	-65.54%-538K	-30.01%506K	-123.82%-161K	-124.89%-57K	-45.80%1.3M	-185.98%-325K
Income before tax	73.15%-2.89M	-190.29%-3.59M	62.89%-4.89M	26.25%-24.54M	43.42%-4.58M	-10.44%-10.75M	138.46%3.98M	-158.44%-13.18M	27.24%-33.28M	15.00%-8.1M
Income tax
Net income	73.15%-2.89M	-190.29%-3.59M	62.89%-4.89M	26.25%-24.54M	43.42%-4.58M	-10.44%-10.75M	138.46%3.98M	-158.44%-13.18M	27.24%-33.28M	15.00%-8.1M
Net income continuous Operations	73.15%-2.89M	-190.29%-3.59M	62.89%-4.89M	26.25%-24.54M	43.42%-4.58M	-10.44%-10.75M	138.46%3.98M	-158.44%-13.18M	27.24%-33.28M	15.00%-8.1M
Minority interest income
Net income attributable to the parent company	73.15%-2.89M	-190.29%-3.59M	62.89%-4.89M	26.25%-24.54M	43.42%-4.58M	-10.44%-10.75M	138.46%3.98M	-158.44%-13.18M	27.24%-33.28M	15.00%-8.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	73.15%-2.89M	-190.29%-3.59M	62.89%-4.89M	26.25%-24.54M	43.42%-4.58M	-10.44%-10.75M	138.46%3.98M	-158.44%-13.18M	27.24%-33.28M	15.00%-8.1M
Basic earnings per share	74.83%-2.19	-176.03%-2.76	72.08%-3.95	40.00%-21.6	62.84%-3.27	16.35%-8.7	132.41%3.63	-152.68%-14.15	36.62%-36	15.38%-8.8
Diluted earnings per share	74.83%-2.19	-176.24%-2.76	72.08%-3.95	40.00%-21.6	62.84%-3.27	16.35%-8.7	132.32%3.62	-152.68%-14.15	36.62%-36	15.38%-8.8
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data